NEMO Gauge multi-center trial – August 2016
Ciel Medical announces the enrollment of the first patient in a multi-center trial on the NEMO Gauge.
https://clinicaltrials.gov, search for “NEMO Gauge”
Kate Garrett, CEO, honored with Ferolyn Fellowship – August 2016
The Ferolyn Fellowship was created as a tribute to the late Ferolyn Powell, an invaluable contributor to the medical device industry, with the goal to improve patient care by supporting promising entrepreneurs with strong leadership skills, passion and aptitude to transform healthcare. Kate Garrett is one of three fellows selected for the inaugural year of the fellowship.
American Thoracic Society, Scientific Advisory Board – May 2016
Ciel Medical sponsored a scientific advisory board meeting with thought leaders in the Ventilator-Associated Pneumonia space to discuss current practices and the Sherpa Suction System. Attendees included Marin Kollef, MD (Washington University School of Medicine), Richard Branson, MS, RRT (University of Cincinnati), Richard Wunderink, MD (Northwestern University), Antonio Anzueto, MD (University of Texas Health Science Center), Saad Nseir, MD (CHRU de Lille) and Neil MacIntyre, MD (Duke University).
Ciel Medical profiled in MedTech Strategist as “Start-up to Watch” – January 2016
Download as PDF
Ciel Medical announces launch of the Sherpa Suction System – October 2015
Download as PDF
Series A1 Financing – June 2015
Ciel Medical has closed their Series A1 financing from leading angel and institutional investors.
Exclusive technology license – April 2015
Ciel Medical has executed an exclusive license to cutting-edge VAP prevention technology from a leading U.S. research university.
EPPIC 11 Company – March 2015
Ciel Medical has been selected as a winner for the 2015 EPPIC 11 awards. EPPIC 11 awards recognize companies that offer cutting-edge ideas, great growth potential, and can make a huge social impact. EPPIC 11 is sponsored by the EPPIC Global Network, a non-profit professional life sciences organization.
Coulter Innovation Forum – February 11th 2015
Ciel Medical has been invited to present at the Coulter Foundation’s first annual Innovation Investor’s Forum. The Coulter Foundation has provided over 450 projects with $130M in investment over the last ten years through their Translational Research Partnerships. Ciel Medical was selected to present as one of the most promising start-up companies funded by Coulter.
BayBio FAST Company – June 2014
Ciel Medical was selected for the second BayBio Fellows All-Star Team (FAST) Advisory Program – a team-based business advising program that connects qualified startups with the strength and experience of the world’s leading life science cluster.
Series A funding – March 2014
Ciel Medical closed their Series A financing from medtech angel investors and private individuals.